JP2024503108A5 - - Google Patents
Info
- Publication number
- JP2024503108A5 JP2024503108A5 JP2023543115A JP2023543115A JP2024503108A5 JP 2024503108 A5 JP2024503108 A5 JP 2024503108A5 JP 2023543115 A JP2023543115 A JP 2023543115A JP 2023543115 A JP2023543115 A JP 2023543115A JP 2024503108 A5 JP2024503108 A5 JP 2024503108A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- promoter
- nucleic acid
- extended
- alphavirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163139297P | 2021-01-19 | 2021-01-19 | |
| US63/139,297 | 2021-01-19 | ||
| PCT/US2022/013004 WO2022159511A2 (en) | 2021-01-19 | 2022-01-19 | Modified alphavirus vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503108A JP2024503108A (ja) | 2024-01-24 |
| JP2024503108A5 true JP2024503108A5 (cg-RX-API-DMAC7.html) | 2025-01-27 |
Family
ID=82549040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543115A Pending JP2024503108A (ja) | 2021-01-19 | 2022-01-19 | 改良型アルファウイルスベクター |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240167057A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4281110A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024503108A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230134138A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117279660A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022210420A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3205216A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304311A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022159511A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022268916A2 (en) * | 2021-06-23 | 2022-12-29 | Ose Immunotherapeutics | Pan-coronavirus peptide vaccine |
| EP4522754A1 (en) * | 2022-05-12 | 2025-03-19 | Sunvax MRNA Therapeutics Inc. | Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator |
| WO2024026553A1 (en) * | 2022-08-03 | 2024-02-08 | Centre Hospitalier De L'université De Montréal | Novel antigenic epitope against sars-cov-2 and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995007994A2 (en) * | 1993-09-15 | 1995-03-23 | Viagene, Inc. | Recombinant alphavirus vectors |
| US20090104226A1 (en) * | 2004-05-21 | 2009-04-23 | Novartis Vaccines And Diagnostics Inc. | Alphavirus Vectors for Respiratory Pathogen Vaccines |
| BR112014008694A2 (pt) * | 2011-10-11 | 2017-06-20 | Novartis Ag | moléculas de ácido nucleico policistrônico recombinante |
| KR102945203B1 (ko) * | 2017-05-08 | 2026-03-31 | 시애틀 프로젝트 코포레이션 | 알파바이러스 신생항원 벡터 |
-
2022
- 2022-01-19 CN CN202280018414.XA patent/CN117279660A/zh active Pending
- 2022-01-19 CA CA3205216A patent/CA3205216A1/en active Pending
- 2022-01-19 KR KR1020237027790A patent/KR20230134138A/ko active Pending
- 2022-01-19 AU AU2022210420A patent/AU2022210420A1/en active Pending
- 2022-01-19 WO PCT/US2022/013004 patent/WO2022159511A2/en not_active Ceased
- 2022-01-19 JP JP2023543115A patent/JP2024503108A/ja active Pending
- 2022-01-19 EP EP22743119.4A patent/EP4281110A4/en active Pending
-
2023
- 2023-07-06 IL IL304311A patent/IL304311A/en unknown
- 2023-07-18 US US18/354,193 patent/US20240167057A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525076A5 (cg-RX-API-DMAC7.html) | ||
| JP2023526495A5 (cg-RX-API-DMAC7.html) | ||
| US20240209379A1 (en) | Compositions and methods for enhancing gene expression | |
| JP2023521662A5 (cg-RX-API-DMAC7.html) | ||
| US20230270841A1 (en) | Coronavirus vaccine | |
| JP2022512912A5 (cg-RX-API-DMAC7.html) | ||
| AU699384B2 (en) | Alphavirus cDNA vectors | |
| US20240123049A1 (en) | Cis-replicon construct | |
| JP2023541108A5 (cg-RX-API-DMAC7.html) | ||
| JP2022534282A5 (cg-RX-API-DMAC7.html) | ||
| WO2008119827A1 (en) | Transreplicase constructs | |
| JP2021524247A5 (cg-RX-API-DMAC7.html) | ||
| US20170314043A1 (en) | Recombinant arterivirus replicon systems and uses thereof | |
| RU2015103891A (ru) | Комплексы белков цитомегаловируса | |
| JP2023509966A5 (cg-RX-API-DMAC7.html) | ||
| JP2002537844A (ja) | ヘルパーウイルス無しで安定な組換えインフルエンザウイルス | |
| JP2023523413A5 (cg-RX-API-DMAC7.html) | ||
| JP2022539417A5 (cg-RX-API-DMAC7.html) | ||
| EP2331557B1 (en) | Alphavirus packaging cell lines | |
| WO2024152996A1 (zh) | 自复制信使核糖核酸疫苗 | |
| EP3865180A1 (en) | Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses | |
| JP2024542126A5 (cg-RX-API-DMAC7.html) | ||
| Ooi et al. | The full-length clone of cucumber green mottle mosaic virus and its application as an expression system for Hepatitis B surface antigen | |
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| WO2025157249A1 (zh) | 一种自复制rna及其用途 |